查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2106581

獸醫即時診斷市場預測至2034年－全球分析（依產品類型、診斷技術、動物種類、適應症、檢體類型、最終使用者、應用、通路和地區分類）

Veterinary Point-of-Care Diagnostics Market Forecasts to 2034 - Global Analysis By Product, Diagnostic Technology, Animal Type, Indication, Sample Type, End User, Application, Distribution Channel, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球獸醫即時診斷市場規模將達到 29 億美元，並在預測期內以 10.9% 的複合年成長率成長，到 2034 年將達到 67 億美元。

獸醫即時診斷是指在患者診療現場或附近進行的診斷測試和系統，從而能夠快速、即時地做出動物健康管理方面的臨床決策。本市場涵蓋儀器和分析儀（包括桌上型和攜帶式/手持式分析儀）、試劑盒、耗材（如試劑組、試劑盒和試劑盒）、品管和校準品，以及軟體和資料管理解決方案。診斷技術包括免疫診斷、分子診斷、臨床生物化學、血液學、血液氣體和電解質分析、尿液檢查、血液凝固檢驗、微生物學和其他診斷技術。寵物數量的增加、對快速診斷結果日益成長的需求、動物慢性疾病和感染疾病的患病率上升以及診斷平台技術的進步是推動各地區市場擴張的主要因素。

對快速準確診斷結果的需求日益成長

對快速、準確的診斷資訊的需求日益成長，從而能夠迅速做出臨床決策，這是推動獸醫即時診斷市場發展的主要動力。獸醫需要快速獲得檢測結果以啟動適當的治療，尤其是在分秒必爭的急診和重症監護情況下。即時診斷消除了將檢體送往實驗室的延誤，使臨床能夠即時採取行動。隨著獸醫病例的日益複雜，飼主對快速解答的期望也越來越高，這推動了對診所內檢測的需求。獸醫學的進步和治療方案的不斷擴展持續增加對快速診斷支援的需求，從而支撐著市場的強勁成長。

設備成本高昂，診所預算有限

即時診斷設備所需的大量資本投入以及持續的耗材成本是限制市場發展的主要因素。先進的分析儀器和診斷平台需要大量的初始投資，這對小規模的獸醫診所來說是一個挑戰。試劑、檢測套組和校準材料等持續的耗材成本也會增加營運支出。獸醫診斷的保險報銷限制也會影響獸醫診所的管理。特別是規模小規模和位於偏遠地區的診所，其預算可能有限，這限制了它們採用此類設備的能力。這些成本障礙會阻礙設備的普及和市場成長，尤其是在發展中地區和小規模的獸醫診所。

小型化和連接方面的技術進步

診斷技術的持續創新，包括小型化、互聯互通和使用者友善平台，為市場拓展帶來了巨大的機會。可攜式和手持式分析儀可在多種環境下進行檢測，例如現場診療、大型動物獸醫診療和移動診所。無線連接和基於雲端的數據管理實現了與臨床管理軟體和遠端醫療平台的無縫整合。人工智慧驅動的觀察解讀和決策支援工具提高了診斷準確性。使用者友善的介面減少了培訓需求。隨著技術的普及和價格的降低，新的應用和用例不斷湧現，從而擴大了市場佔有率和目標市場。

與外包測試機構和集中式測試服務的競爭

來自現有實驗室和集中式檢測服務的競爭對獸醫即時診斷市場構成重大威脅。實驗室提供全面的檢測項目、專業技術和規模經濟優勢。有些獸醫可能更傾向於將複雜病例或即時診斷能力有限的情況外包給外部實驗室。集中式實驗室也可能因其檢體採集便利性和報告全面性而受到青睞。從成本角度來看，對於某些檢測項目，外部實驗室可能更經濟。競爭可能會限制即時診斷在某些檢測類別和臨床環境中的應用。

新型冠狀病毒（COVID-19）的影響：

新冠疫情對獸醫照護現場診斷市場產生了重大影響。初期，疫情封鎖期間寵物就診量下降，供應鏈中斷，導致市場受到衝擊。然而，疫情期間寵物數量激增，也帶動了就診量的增加。疫情也加速了快速診斷和院內檢測能力的需求。對感染控制和生物安全的日益重視也提升了人們對照護現場解決方案的興趣。遠端醫療的普及增加了對綜合診斷數據的需求。疫情結束後，寵物飼養量的持續成長和對快速診斷的關注推動了市場成長，獸醫診所也繼續增加對即時診斷能力的投入。

在預測期內，「儀器和分析儀器」細分市場預計將佔據最大的市場佔有率。

預計在整個預測期內，「儀器和分析設備」細分市場將佔據最大的市場佔有率。這主要得益於診斷平台在實現涵蓋多種檢測類別的全面即時檢測方面發揮的關鍵作用。包括桌上型和攜帶式/手持式系統在內的儀器和分析設備構成了獸醫即時診斷的基礎，為執行檢測和計算結果提供了必要的硬體。該細分市場受益於持續的技術創新，例如小型化和連接性的提升。此外，設備的持續更新換代也支撐了市場需求。隨著獸醫院不斷增加對診斷能力的投入，預計儀器和分析設備仍將是最大的產品細分市場，並在整個預測期內保持最大的市場佔有率。

預計在預測期內，分子診斷領域將呈現最高的複合年成長率。

在預測期內，分子診斷領域預計將呈現最高的成長率，這主要得益於市場對快速、準確的感染疾病檢測需求不斷成長、即時分子診斷平台應用日益廣泛以及技術進步帶來的更簡便、更快捷的檢測方式。分子診斷技術，包括基於PCR和等溫擴增的檢測方法，在基因層面檢測病原體具有很高的靈敏度和特異性。該領域受益於傳染病檢查、基因檢測和抗生素抗藥性檢測等應用的不斷擴展。適用於即時檢測的便利快速分子診斷平台的日益普及正在推動其應用。隨著分子檢測變得更加便利、經濟，該領域正經歷著市場中最快的成長。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這主要得益於其較高的寵物擁有率、強勁的獸醫保健支出以及成熟的即時診斷技術的廣泛應用。美國憑藉其完善的獸醫基礎設施和較高的診斷測試利用率，正引領著區域市場的成長。寵物飼主對先進診斷方案的高度認知也支撐著市場需求。診斷設備製造商的強大實力推動了創新。成熟的獸醫轉診網路和專科診所創造了穩定的需求。由於寵物醫療費用支出高昂且獸醫基礎設施完善，北美將繼續保持其市場主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於寵物擁有量的成長、可支配收入的增加以及中國、印度、澳大利亞和東南亞等國家對先進獸醫診斷技術的認知度不斷提高。該地區寵物擁有量的快速成長和中產階級的壯大，正在創造對獸醫服務的巨大需求。獸醫實踐的現代化和新技術的應用正在加速。對獸醫教育和診斷基礎設施投入的增加，也為市場擴張提供了支持。人們對即時診斷益處的認知不斷提高，以及寵物保險覆蓋範圍的擴大，進一步加速了即時診斷技術的普及。隨著獸醫學的進步和寵物相關支出的成長，亞太地區在全球獸醫即時診斷市場中正經歷最快的成長。

免費客製化服務：

所有購買此報告的客戶均可從以下免費自訂選項中選擇一項：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球獸醫即時診斷市場：依產品分類

  • 儀器/分析儀
    • 桌面分析儀
    • 可攜式/手持式分析儀器
  • 檢測套組和耗材
    • 試劑組
    • 測試條
    • 墨水匣和磁帶
    • 控制和校準器
  • 軟體和數據管理解決方案

第6章 全球獸醫即時診斷市場：依診斷技術分類

  • 免疫診斷
    • 橫向流動化驗
    • 基於ELISA方法的快速檢測
  • 分子診斷
    • 基於PCR的檢測
    • 等溫擴增試驗
  • 臨床生物化學
  • 血液學
  • 血氣和電解質分析
  • 尿液檢查
  • 血液凝固檢驗
  • 微生物檢測
  • 其他診斷技術

第7章 全球獸醫即時診斷市場：依動物類型分類

  • 伴侶動物
    • 狗
    • 貓
    • 馬
    • 其他伴侶動物
  • 家畜
    • 牛
    • 豬
    • 家禽
    • 綿羊和山羊
    • 其他牲畜

第8章 全球獸醫即時診斷市場：依適應症分類

  • 感染疾病
  • 寄生蟲病
  • 內分泌疾病
  • 心臟病
  • 腎臟疾病
  • 肝病
  • 消化系統疾病
  • 呼吸系統疾病
  • 生殖疾病
  • 代謝性疾病
  • 其他改編

第9章 全球獸醫即時診斷市場：依樣本類型分類

  • 血
  • 血清和血漿
  • 尿
  • 糞便檢體
  • 唾液
  • 組織檢體
  • 牛奶
  • 其他檢體類型

第10章：全球獸醫即時診斷市場：以最終用戶分類

  • 獸醫醫院和診所
  • 獸醫診斷檢測實驗室
  • 畜牧場和酪農
  • 研究機構和大學
  • 動物收容所及救援中心
  • 居家醫療
  • 其他最終用戶

第11章 全球獸醫即時診斷市場：按應用分類

  • 疾病診斷
  • 健康檢查
  • 妊娠測試
  • 術前檢查
  • 治療監測
  • 監測牲畜健康狀況
  • 緊急和緊急醫療診斷
  • 其他用途

第12章 全球獸醫即時診斷市場：依通路分類

  • 直銷
  • 獸藥批發商
  • 零售藥房
  • 電子商務平台
  • 其他分銷管道

第13章 全球獸醫即時診斷市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第14章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第15章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品上市及法規核准
  • 擴大生產能力和投資
  • 其他策略舉措

第16章：公司簡介

  • IDEXX Laboratories, Inc.
  • Zoetis Inc.
  • Heska Corporation
  • Virbac SA
  • Thermo Fisher Scientific Inc.
  • FUJIFILM Corporation
  • Randox Laboratories Ltd.
  • bioMerieux SA
  • QIAGEN NV
  • BioNote, Inc.
  • SEKISUI Diagnostics, LLC
  • Woodley Equipment Company Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • INDICAL BIOSCIENCE GmbH
  • Bionote USA Inc.
  • Neogen Corporation
Product Code: SMRC38672

According to Stratistics MRC, the Global Veterinary Point-of-Care Diagnostics Market is accounted for $2.9 billion in 2026 and is expected to reach $6.7 billion by 2034 growing at a CAGR of 10.9% during the forecast period. Veterinary point-of-care diagnostics refer to diagnostic tests and systems performed at or near the site of patient care, enabling rapid, real-time clinical decision-making for animal health. The market encompasses instruments and analyzers including benchtop and portable/handheld analyzers, test kits and consumables such as reagent kits, test strips, cartridges and cassettes, and controls and calibrators, along with software and data management solutions. Diagnostic technologies include immunodiagnostics, molecular diagnostics, clinical biochemistry, hematology, blood gas and electrolyte analysis, urinalysis, coagulation testing, microbiology testing, and other diagnostic technologies. Growing pet ownership, increasing demand for rapid diagnostic results, rising prevalence of chronic and infectious diseases in animals, and technological advancements in diagnostic platforms are key drivers of market expansion across all regions.

Market Dynamics:

Driver:

Growing demand for rapid and accurate diagnostic results

The increasing need for timely and accurate diagnostic information to enable prompt clinical decision-making is a primary driver for the veterinary point-of-care diagnostics market. Veterinarians require rapid test results to initiate appropriate treatment, particularly in emergency and critical care situations where time is critical. Point-of-care diagnostics eliminate the delays associated with sending samples to reference laboratories, enabling immediate clinical action. The growing complexity of veterinary cases and increasing owner expectations for rapid answers drive demand for in-clinic testing. As veterinary medicine advances and treatment options expand, the need for rapid diagnostic support continues growing, sustaining strong market expansion.

Restraint:

High equipment costs and limited practice budgets

The significant capital investment required for point-of-care diagnostic equipment and ongoing consumable costs represent a major restraint for the market. Advanced analyzers and diagnostic platforms require substantial upfront investment that may be challenging for smaller practices. Ongoing consumable costs including reagents, test kits, and calibrators add to operational expenses. Reimbursement limitations for veterinary diagnostics affect practice economics. Limited budgets, particularly in small and rural practices, may restrict equipment acquisition. These cost barriers may limit adoption and market growth, especially in developing regions and among smaller veterinary practices.

Opportunity:

Technological advancements in miniaturization and connectivity

Continuous innovation in diagnostic technologies including miniaturization, connectivity, and user-friendly platforms presents significant opportunities for market expansion. Portable and handheld analyzers enable testing in diverse settings including field practice, large animal medicine, and mobile clinics. Wireless connectivity and cloud-based data management enable seamless integration with practice management software and telemedicine platforms. AI-powered interpretation and decision support tools are enhancing diagnostic accuracy. User-friendly interfaces reduce training requirements. As technology becomes more accessible and affordable, new applications and expanded access capture growing market share, expanding the addressable market.

Threat:

Competition from reference laboratories and centralized testing

Competition from established reference laboratories and centralized testing services poses significant threats to the veterinary point-of-care diagnostics market. Reference laboratories offer comprehensive test menus, specialized expertise, and economies of scale. Some veterinarians may prefer referral laboratory testing for complex cases or when point-of-care capabilities are limited. The convenience of sample pickup and comprehensive reporting may favor centralized testing. Cost considerations may make reference laboratory testing more economical for certain tests. This competition may limit point-of-care adoption for certain test categories and practices.

Covid-19 Impact:

The COVID-19 pandemic had a significant impact on the veterinary point-of-care diagnostics market. Initial disruptions included reduced veterinary visits during lockdowns and supply chain interruptions. However, pet adoption surged during the pandemic, expanding the patient population. The pandemic accelerated demand for rapid diagnostics and in-clinic testing capabilities. Increased focus on infection control and biosecurity drove interest in point-of-care solutions. Telemedicine expansion increased demand for diagnostic data connectivity. Post-pandemic, elevated pet ownership and continued focus on rapid diagnostics have sustained market growth, with practices maintaining investment in point-of-care capabilities.

The Instruments and Analyzers segment is expected to be the largest during the forecast period

The Instruments and Analyzers segment is expected to account for the largest market share during the forecast period, driven by the essential role of diagnostic platforms in enabling comprehensive point-of-care testing across multiple test categories. Instruments and analyzers including benchtop and portable/handheld systems are the foundation of veterinary point-of-care diagnostics, providing the hardware necessary for conducting tests and generating results. The segment benefits from continuous innovation including miniaturization and connectivity advancements. Ongoing replacement and upgrade cycles sustain demand. As practices invest in diagnostic capabilities, instruments and analyzers remain the largest product segment, securing the largest market share throughout the forecast period.

The Molecular Diagnostics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Molecular Diagnostics segment is predicted to witness the highest growth rate, fueled by increasing demand for rapid, accurate infectious disease detection, growing availability of point-of-care molecular platforms, and technological advancements enabling simpler, faster testing. Molecular diagnostics including PCR-based tests and isothermal amplification tests offer high sensitivity and specificity for detecting pathogens at the genetic level. The segment benefits from expanding applications in infectious disease testing, genetic testing, and antimicrobial resistance detection. Growing availability of user-friendly, rapid molecular platforms suitable for point-of-care use is driving adoption. As molecular testing becomes more accessible and affordable, this segment delivers the fastest market growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership rates, strong veterinary spending, and established point-of-care diagnostics adoption. The United States leads regional market growth with extensive veterinary practice infrastructure and high diagnostic testing utilization. High awareness of advanced diagnostic options among pet owners supports demand. Strong presence of diagnostic equipment manufacturers drives innovation. Established veterinary reference networks and specialty practices create consistent demand. With high pet healthcare spending and advanced veterinary infrastructure, North America maintains its dominant market position.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by rising pet ownership, increasing disposable incomes, and growing awareness of advanced veterinary diagnostics across countries including China, India, Australia, and Southeast Asia. The region's rapidly growing pet population and expanding middle class create substantial demand for veterinary services. Veterinary practice modernization and technology adoption are accelerating. Increasing investment in veterinary education and diagnostic infrastructure supports market expansion. Growing awareness of point-of-care diagnostics benefits and expanding pet insurance coverage further accelerate adoption. As veterinary healthcare develops and pet spending increases, Asia Pacific delivers the fastest veterinary point-of-care diagnostics market growth globally.

Key players in the market

Some of the key players in Veterinary Point-of-Care Diagnostics Market include IDEXX Laboratories, Inc., Zoetis Inc., Heska Corporation, Virbac S.A., Thermo Fisher Scientific Inc., FUJIFILM Corporation, Randox Laboratories Ltd., bioMerieux SA, QIAGEN N.V., BioNote, Inc., SEKISUI Diagnostics, LLC, Woodley Equipment Company Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., INDICAL BIOSCIENCE GmbH, Bionote USA Inc., and Neogen Corporation.

Key Developments:

In May 2026, IDEXX Laboratories expanded its Fecal Dx antigen testing platform by adding Taeniid tapeworm detection capabilities to improve point-of-care parasitic screening for companion animals.

In March 2026, Zoetis entered into a definitive agreement to acquire the global animal genomics business from Neogen Corporation, expanding its precision animal health and predictive diagnostic insights portfolio across livestock and companion animals.

In March 2026, Neogen Corporation announced the divestiture of its global animal genomics business unit to Zoetis, realigning its resources to focus on core food safety, indicator media, and specialized point-of-care sanitation platforms.

In September 2025, FUJIFILM Healthcare Europe launched the FUJI DRI-CHEM AU20V in-house diagnostics measurement device, featuring automated dilution and Surface Plasmon Fluorescence (SPF) technology to deliver point-of-care endocrine and hormone results in 10 minutes.

Products Covered:

  • Instruments and Analyzers
  • Test Kits and Consumables
  • Software and Data Management Solutions

Diagnostic Technologies Covered:

  • Immunodiagnostics
  • Molecular Diagnostics
  • Clinical Biochemistry
  • Hematology
  • Blood Gas and Electrolyte Analysis
  • Urinalysis
  • Coagulation Testing
  • Microbiology Testing
  • Other Diagnostic Technologies

Animal Types Covered:

  • Companion Animals
  • Livestock Animals

Indications Covered:

  • Infectious Diseases
  • Parasitic Diseases
  • Endocrine Disorders
  • Cardiac Disorders
  • Renal Diseases
  • Hepatic Diseases
  • Gastrointestinal Disorders
  • Respiratory Diseases
  • Reproductive Health Disorders
  • Metabolic Disorders
  • Other Indications

Sample Types Covered:

  • Blood
  • Serum and Plasma
  • Urine
  • Fecal Samples
  • Saliva
  • Tissue Samples
  • Milk
  • Other Sample Types

End Users Covered:

  • Veterinary Hospitals and Clinics
  • Veterinary Diagnostic Laboratories
  • Livestock Farms and Dairy Farms
  • Research Institutes and Universities
  • Animal Shelters and Rescue Centers
  • Home Care Settings
  • Other End Users

Applications Covered:

  • Disease Diagnosis
  • Wellness Screening
  • Pregnancy Testing
  • Pre-Surgical Testing
  • Treatment Monitoring
  • Herd Health Monitoring
  • Emergency and Critical Care Diagnostics
  • Other Applications

Distribution Channels Covered:

  • Direct Sales
  • Veterinary Distributors
  • Retail Pharmacies
  • E-Commerce Platforms
  • Other Distribution Channels

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Veterinary Point-of-Care Diagnostics Market, By Product

  • 5.1 Instruments and Analyzers
    • 5.1.1 Benchtop Analyzers
    • 5.1.2 Portable/Handheld Analyzers
  • 5.2 Test Kits and Consumables
    • 5.2.1 Reagent Kits
    • 5.2.2 Test Strips
    • 5.2.3 Cartridges and Cassettes
    • 5.2.4 Controls and Calibrators
  • 5.3 Software and Data Management Solutions

6 Global Veterinary Point-of-Care Diagnostics Market, By Diagnostic Technology

  • 6.1 Immunodiagnostics
    • 6.1.1 Lateral Flow Assays
    • 6.1.2 ELISA-Based Rapid Tests
  • 6.2 Molecular Diagnostics
    • 6.2.1 PCR-Based Tests
    • 6.2.2 Isothermal Amplification Tests
  • 6.3 Clinical Biochemistry
  • 6.4 Hematology
  • 6.5 Blood Gas and Electrolyte Analysis
  • 6.6 Urinalysis
  • 6.7 Coagulation Testing
  • 6.8 Microbiology Testing
  • 6.9 Other Diagnostic Technologies

7 Global Veterinary Point-of-Care Diagnostics Market, By Animal Type

  • 7.1 Companion Animals
    • 7.1.1 Dogs
    • 7.1.2 Cats
    • 7.1.3 Horses
    • 7.1.4 Other Companion Animals
  • 7.2 Livestock Animals
    • 7.2.1 Cattle
    • 7.2.2 Swine
    • 7.2.3 Poultry
    • 7.2.4 Sheep and Goats
    • 7.2.5 Other Livestock Animals

8 Global Veterinary Point-of-Care Diagnostics Market, By Indication

  • 8.1 Infectious Diseases
  • 8.2 Parasitic Diseases
  • 8.3 Endocrine Disorders
  • 8.4 Cardiac Disorders
  • 8.5 Renal Diseases
  • 8.6 Hepatic Diseases
  • 8.7 Gastrointestinal Disorders
  • 8.8 Respiratory Diseases
  • 8.9 Reproductive Health Disorders
  • 8.10 Metabolic Disorders
  • 8.11 Other Indications

9 Global Veterinary Point-of-Care Diagnostics Market, By Sample Type

  • 9.1 Blood
  • 9.2 Serum and Plasma
  • 9.3 Urine
  • 9.4 Fecal Samples
  • 9.5 Saliva
  • 9.6 Tissue Samples
  • 9.7 Milk
  • 9.8 Other Sample Types

10 Global Veterinary Point-of-Care Diagnostics Market, By End User

  • 10.1 Veterinary Hospitals and Clinics
  • 10.2 Veterinary Diagnostic Laboratories
  • 10.3 Livestock Farms and Dairy Farms
  • 10.4 Research Institutes and Universities
  • 10.5 Animal Shelters and Rescue Centers
  • 10.6 Home Care Settings
  • 10.7 Other End Users

11 Global Veterinary Point-of-Care Diagnostics Market, By Application

  • 11.1 Disease Diagnosis
  • 11.2 Wellness Screening
  • 11.3 Pregnancy Testing
  • 11.4 Pre-Surgical Testing
  • 11.5 Treatment Monitoring
  • 11.6 Herd Health Monitoring
  • 11.7 Emergency and Critical Care Diagnostics
  • 11.8 Other Applications

12 Global Veterinary Point-of-Care Diagnostics Market, By Distribution Channel

  • 12.1 Direct Sales
  • 12.2 Veterinary Distributors
  • 12.3 Retail Pharmacies
  • 12.4 E-Commerce Platforms
  • 12.5 Other Distribution Channels

13 Global Veterinary Point-of-Care Diagnostics Market, By Geography

  • 13.1 North America
    • 13.1.1 United States
    • 13.1.2 Canada
    • 13.1.3 Mexico
  • 13.2 Europe
    • 13.2.1 United Kingdom
    • 13.2.2 Germany
    • 13.2.3 France
    • 13.2.4 Italy
    • 13.2.5 Spain
    • 13.2.6 Netherlands
    • 13.2.7 Belgium
    • 13.2.8 Sweden
    • 13.2.9 Switzerland
    • 13.2.10 Poland
    • 13.2.11 Rest of Europe
  • 13.3 Asia Pacific
    • 13.3.1 China
    • 13.3.2 Japan
    • 13.3.3 India
    • 13.3.4 South Korea
    • 13.3.5 Australia
    • 13.3.6 Indonesia
    • 13.3.7 Thailand
    • 13.3.8 Malaysia
    • 13.3.9 Singapore
    • 13.3.10 Vietnam
    • 13.3.11 Rest of Asia Pacific
  • 13.4 South America
    • 13.4.1 Brazil
    • 13.4.2 Argentina
    • 13.4.3 Colombia
    • 13.4.4 Chile
    • 13.4.5 Peru
    • 13.4.6 Rest of South America
  • 13.5 Rest of the World (RoW)
    • 13.5.1 Middle East
      • 13.5.1.1 Saudi Arabia
      • 13.5.1.2 United Arab Emirates
      • 13.5.1.3 Qatar
      • 13.5.1.4 Israel
      • 13.5.1.5 Rest of Middle East
    • 13.5.2 Africa
      • 13.5.2.1 South Africa
      • 13.5.2.2 Egypt
      • 13.5.2.3 Morocco
      • 13.5.2.4 Rest of Africa

14 Strategic Market Intelligence

  • 14.1 Industry Value Network and Supply Chain Assessment
  • 14.2 White-Space and Opportunity Mapping
  • 14.3 Product Evolution and Market Life Cycle Analysis
  • 14.4 Channel, Distributor, and Go-to-Market Assessment

15 Industry Developments and Strategic Initiatives

  • 15.1 Mergers and Acquisitions
  • 15.2 Partnerships, Alliances, and Joint Ventures
  • 15.3 New Product Launches and Regulatory Approvals
  • 15.4 Capacity Expansion and Investments
  • 15.5 Other Strategic Initiatives

16 Company Profiles

  • 16.1 IDEXX Laboratories, Inc.
  • 16.2 Zoetis Inc.
  • 16.3 Heska Corporation
  • 16.4 Virbac S.A.
  • 16.5 Thermo Fisher Scientific Inc.
  • 16.6 FUJIFILM Corporation
  • 16.7 Randox Laboratories Ltd.
  • 16.8 bioMerieux SA
  • 16.9 QIAGEN N.V.
  • 16.10 BioNote, Inc.
  • 16.11 SEKISUI Diagnostics, LLC
  • 16.12 Woodley Equipment Company Ltd.
  • 16.13 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 16.14 INDICAL BIOSCIENCE GmbH
  • 16.15 Bionote USA Inc.
  • 16.16 Neogen Corporation

List of Tables

  • 1 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Region (2023-2034) ($MN)
  • 2 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Product (2023-2034) ($MN)
  • 3 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Instruments and Analyzers (2023-2034) ($MN)
  • 4 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Benchtop Analyzers (2023-2034) ($MN)
  • 5 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Portable/Handheld Analyzers (2023-2034) ($MN)
  • 6 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Test Kits and Consumables (2023-2034) ($MN)
  • 7 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Reagent Kits (2023-2034) ($MN)
  • 8 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Test Strips (2023-2034) ($MN)
  • 9 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Cartridges and Cassettes (2023-2034) ($MN)
  • 10 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Controls and Calibrators (2023-2034) ($MN)
  • 11 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Software and Data Management Solutions (2023-2034) ($MN)
  • 12 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Diagnostic Technology (2023-2034) ($MN)
  • 13 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Immunodiagnostics (2023-2034) ($MN)
  • 14 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Lateral Flow Assays (2023-2034) ($MN)
  • 15 Global Veterinary Point-of-Care Diagnostics Market Outlook, By ELISA-Based Rapid Tests (2023-2034) ($MN)
  • 16 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Molecular Diagnostics (2023-2034) ($MN)
  • 17 Global Veterinary Point-of-Care Diagnostics Market Outlook, By PCR-Based Tests (2023-2034) ($MN)
  • 18 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Isothermal Amplification Tests (2023-2034) ($MN)
  • 19 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Clinical Biochemistry (2023-2034) ($MN)
  • 20 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Hematology (2023-2034) ($MN)
  • 21 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Blood Gas and Electrolyte Analysis (2023-2034) ($MN)
  • 22 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Urinalysis (2023-2034) ($MN)
  • 23 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Coagulation Testing (2023-2034) ($MN)
  • 24 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Microbiology Testing (2023-2034) ($MN)
  • 25 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Other Diagnostic Technologies (2023-2034) ($MN)
  • 26 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Animal Type (2023-2034) ($MN)
  • 27 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Companion Animals (2023-2034) ($MN)
  • 28 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Dogs (2023-2034) ($MN)
  • 29 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Cats (2023-2034) ($MN)
  • 30 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Horses (2023-2034) ($MN)
  • 31 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Other Companion Animals (2023-2034) ($MN)
  • 32 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Livestock Animals (2023-2034) ($MN)
  • 33 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Cattle (2023-2034) ($MN)
  • 34 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Swine (2023-2034) ($MN)
  • 35 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Poultry (2023-2034) ($MN)
  • 36 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Sheep and Goats (2023-2034) ($MN)
  • 37 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Other Livestock Animals (2023-2034) ($MN)
  • 38 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Indication (2023-2034) ($MN)
  • 39 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Infectious Diseases (2023-2034) ($MN)
  • 40 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Parasitic Diseases (2023-2034) ($MN)
  • 41 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Endocrine Disorders (2023-2034) ($MN)
  • 42 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Cardiac Disorders (2023-2034) ($MN)
  • 43 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Renal Diseases (2023-2034) ($MN)
  • 44 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Hepatic Diseases (2023-2034) ($MN)
  • 45 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Gastrointestinal Disorders (2023-2034) ($MN)
  • 46 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Respiratory Diseases (2023-2034) ($MN)
  • 47 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Reproductive Health Disorders (2023-2034) ($MN)
  • 48 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Metabolic Disorders (2023-2034) ($MN)
  • 49 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Other Indications (2023-2034) ($MN)
  • 50 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Sample Type (2023-2034) ($MN)
  • 51 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Blood (2023-2034) ($MN)
  • 52 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Serum and Plasma (2023-2034) ($MN)
  • 53 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Urine (2023-2034) ($MN)
  • 54 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Fecal Samples (2023-2034) ($MN)
  • 55 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Saliva (2023-2034) ($MN)
  • 56 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Tissue Samples (2023-2034) ($MN)
  • 57 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Milk (2023-2034) ($MN)
  • 58 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Other Sample Types (2023-2034) ($MN)
  • 59 Global Veterinary Point-of-Care Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • 60 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Veterinary Hospitals and Clinics (2023-2034) ($MN)
  • 61 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Veterinary Diagnostic Laboratories (2023-2034) ($MN)
  • 62 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Livestock Farms and Dairy Farms (2023-2034) ($MN)
  • 63 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Research Institutes and Universities (2023-2034) ($MN)
  • 64 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Animal Shelters and Rescue Centers (2023-2034) ($MN)
  • 65 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Home Care Settings (2023-2034) ($MN)
  • 66 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)
  • 67 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Application (2023-2034) ($MN)
  • 68 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Disease Diagnosis (2023-2034) ($MN)
  • 69 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Wellness Screening (2023-2034) ($MN)
  • 70 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Pregnancy Testing (2023-2034) ($MN)
  • 71 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Pre-Surgical Testing (2023-2034) ($MN)
  • 72 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Treatment Monitoring (2023-2034) ($MN)
  • 73 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Herd Health Monitoring (2023-2034) ($MN)
  • 74 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Emergency and Critical Care Diagnostics (2023-2034) ($MN)
  • 75 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Other Applications (2023-2034) ($MN)
  • 76 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • 77 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Direct Sales (2023-2034) ($MN)
  • 78 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Veterinary Distributors (2023-2034) ($MN)
  • 79 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • 80 Global Veterinary Point-of-Care Diagnostics Market Outlook, By E-Commerce Platforms (2023-2034) ($MN)
  • 81 Global Veterinary Point-of-Care Diagnostics Market Outlook, By Other Distribution Channels (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.